1. Home
  2. ICHR vs ESPR Comparison

ICHR vs ESPR Comparison

Compare ICHR & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICHR
  • ESPR
  • Stock Information
  • Founded
  • ICHR 1999
  • ESPR 2008
  • Country
  • ICHR United States
  • ESPR United States
  • Employees
  • ICHR N/A
  • ESPR N/A
  • Industry
  • ICHR Semiconductors
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICHR Technology
  • ESPR Health Care
  • Exchange
  • ICHR Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • ICHR 581.2M
  • ESPR 534.3M
  • IPO Year
  • ICHR 2016
  • ESPR 2013
  • Fundamental
  • Price
  • ICHR $19.13
  • ESPR $3.11
  • Analyst Decision
  • ICHR Strong Buy
  • ESPR Buy
  • Analyst Count
  • ICHR 6
  • ESPR 6
  • Target Price
  • ICHR $29.80
  • ESPR $6.50
  • AVG Volume (30 Days)
  • ICHR 1.1M
  • ESPR 7.0M
  • Earning Date
  • ICHR 11-03-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • ICHR N/A
  • ESPR N/A
  • EPS Growth
  • ICHR N/A
  • ESPR N/A
  • EPS
  • ICHR N/A
  • ESPR N/A
  • Revenue
  • ICHR $929,180,000.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • ICHR $14.64
  • ESPR $13.05
  • Revenue Next Year
  • ICHR $5.82
  • ESPR N/A
  • P/E Ratio
  • ICHR N/A
  • ESPR N/A
  • Revenue Growth
  • ICHR 15.45
  • ESPR N/A
  • 52 Week Low
  • ICHR $13.12
  • ESPR $0.69
  • 52 Week High
  • ICHR $36.48
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • ICHR 55.05
  • ESPR 73.44
  • Support Level
  • ICHR $16.52
  • ESPR $2.35
  • Resistance Level
  • ICHR $21.42
  • ESPR $3.41
  • Average True Range (ATR)
  • ICHR 1.09
  • ESPR 0.17
  • MACD
  • ICHR 0.29
  • ESPR 0.00
  • Stochastic Oscillator
  • ICHR 52.96
  • ESPR 71.70

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: